- JP-listed companies
- StemCell Institute
StemCell InstituteJP:7096
Market cap
¥16.7B
P/E ratio
53.6x
Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | |
Net sales | 1,150 | 1,676 | 1,410 | 1,782 | 2,091 | 2,481 |
Cost of sales | 389 | 544 | 485 | 671 | 755 | 905 |
Gross profit (loss) | 761 | 1,133 | 924 | 1,111 | 1,336 | 1,576 |
Selling, general and administrative expenses | 545 | 750 | 837 | 884 | 1,038 | 1,162 |
Operating profit (loss) | 216 | 382 | 87 | 227 | 298 | 414 |
Interest income | 0 | 0 | 0 | 1 | 2 | 4 |
Subsidy income | 0 | 0 | 5 | - | 0 | 1 |
Sponsorship money income | - | - | - | - | - | 3 |
Miscellaneous income | - | - | - | - | 1 | 1 |
Non-operating income | 0 | 0 | 6 | 1 | 3 | 8 |
Settlement money-NOE | - | - | - | - | - | 2 |
Outsourcing expenses-NOE | - | - | - | - | - | 3 |
Non-operating expenses | 0 | 0 | - | 16 | - | 5 |
Ordinary profit (loss) | 216 | 383 | 92 | 213 | 300 | 417 |
Gain on sale of investment securities | - | - | - | - | - | 22 |
Other | - | - | - | - | - | 2 |
Extraordinary income | - | - | - | - | - | 24 |
Head office relocation expenses | - | - | - | - | 21 | - |
Loss on retirement of non-current assets | 1 | - | 1 | - | - | 0 |
Extraordinary losses | 1 | - | 1 | - | 21 | 0 |
Profit (loss) before income taxes | 215 | 383 | 91 | 213 | 279 | 441 |
Income taxes - current | 76 | 114 | 27 | 82 | 95 | 128 |
Income taxes - deferred | -4 | -9 | 2 | -3 | -14 | 2 |
Income taxes | 72 | 105 | 29 | 79 | 81 | 130 |
Profit (loss) | 143 | 277 | 62 | 134 | 198 | 311 |